Literature DB >> 31784374

Tau-positron emission tomography correlates with neuropathology findings.

Val J Lowe1, Emily S Lundt2, Sabrina M Albertson2, Hoon-Ki Min1, Ping Fang1, Scott A Przybelski2, Matthew L Senjem3, Christopher G Schwarz1, Kejal Kantarci1, Bradley Boeve4, David T Jones4, R Ross Reichard5, Jessica F Tranovich6, Fadi S Hanna Al-Shaikh6, David S Knopman4, Clifford R Jack1, Dennis W Dickson6,7, Ronald C Petersen4, Melissa E Murray6.   

Abstract

INTRODUCTION: Comparison of tau (flortaucipir) positron emission tomography (FTP-PET) to autopsy is important to demonstrate the relationship of FTP-PET to neuropathologic findings.
METHODS: Autopsies were performed on 26 participants who had antemortem FTP-PET. FTP-PET standardized uptake value ratios (SUVRs) were compared to autopsy diagnoses and Braak tangle stage. Quantitative tau burden was compared to regional FTP-PET signal.
RESULTS: Participants with Braak stages of IV or greater had elevated FTP-PET signal. FTP-PET was elevated in participants with Alzheimer's disease. An FTP-PET SUVR cut point of 1.29 was determined to be optimal. Quantitative measurements of hippocampal and temporal lobe tau burden were highly correlated to FTP-PET signal (rho's from 0.61 to 0.70, P ≤ .02). DISCUSSION: Elevated FTP-PET reflects Braak IV or greater neuropathology. Participants with primary age-related tauopathy and hippocampal sclerosis did not show elevated FTP-PET signal. Secondary neuropathologic diagnoses of Alzheimer's disease neuropathologic change can lead to borderline elevated FTP-PET signal.
© 2019 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; Autopsy; Braak tangle stage; PET; Tau; flortaucipir

Mesh:

Substances:

Year:  2020        PMID: 31784374      PMCID: PMC7067654          DOI: 10.1016/j.jalz.2019.09.079

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  43 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

Authors:  K Kosaka; M Yoshimura; K Ikeda; H Budka
Journal:  Clin Neuropathol       Date:  1984 Sep-Oct       Impact factor: 1.368

3.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

4.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

Review 5.  Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.

Authors:  Melissa E Murray; Naomi Kouri; Wen-Lang Lin; Clifford R Jack; Dennis W Dickson; Prashanthi Vemuri
Journal:  Alzheimers Res Ther       Date:  2014-01-02       Impact factor: 6.982

6.  An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.

Authors:  Mekala R Raman; Christopher G Schwarz; Melissa E Murray; Val J Lowe; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2016-03-28       Impact factor: 2.486

7.  Longitudinal tau PET in ageing and Alzheimer's disease.

Authors:  Clifford R Jack; Heather J Wiste; Christopher G Schwarz; Val J Lowe; Matthew L Senjem; Prashanthi Vemuri; Stephen D Weigand; Terry M Therneau; Dave S Knopman; Jeffrey L Gunter; David T Jones; Jonathan Graff-Radford; Kejal Kantarci; Rosebud O Roberts; Michelle M Mielke; Mary M Machulda; Ronald C Petersen
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

8.  Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.

Authors:  Marta Marquié; Eline E Verwer; Avery C Meltzer; Sally Ji Who Kim; Cinthya Agüero; Jose Gonzalez; Sara J Makaretz; Michael Siao Tick Chong; Prianca Ramanan; Ana C Amaral; Marc D Normandin; Charles R Vanderburg; Stephen N Gomperts; Keith A Johnson; Matthew P Frosch; Teresa Gómez-Isla
Journal:  Acta Neuropathol Commun       Date:  2017-10-19       Impact factor: 7.801

9.  An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Authors:  Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray
Journal:  Acta Neuropathol Commun       Date:  2016-06-13       Impact factor: 7.801

10.  Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals.

Authors:  Val J Lowe; Emily Lundt; David Knopman; Matthew L Senjem; Jeffrey L Gunter; Christopher G Schwarz; Bradley J Kemp; Clifford R Jack; Ronald C Petersen
Journal:  Neuroimage Clin       Date:  2017-08-14       Impact factor: 4.881

View more
  38 in total

1.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

2.  Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.

Authors:  Alma Ghirelli; Nirubol Tosakulwong; Stephen D Weigand; Heather M Clark; Farwa Ali; Hugo Botha; Joseph R Duffy; Rene L Utianski; Marina Buciuc; Melissa E Murray; Sydney A Labuzan; Anthony J Spychalla; Nha Trang Thu Pham; Christopher G Schwarz; Matthew L Senjem; Mary M Machulda; Matthew Baker; Rosa Rademakers; Massimo Filippi; Clifford R Jack; Val J Lowe; Joseph E Parisi; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Ann Neurol       Date:  2020-09-12       Impact factor: 10.422

3.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

4.  Four distinct trajectories of tau deposition identified in Alzheimer's disease.

Authors:  Jacob W Vogel; Alexandra L Young; Neil P Oxtoby; Ruben Smith; Rik Ossenkoppele; Olof T Strandberg; Renaud La Joie; Leon M Aksman; Michel J Grothe; Yasser Iturria-Medina; Michael J Pontecorvo; Michael D Devous; Gil D Rabinovici; Daniel C Alexander; Chul Hyoung Lyoo; Alan C Evans; Oskar Hansson
Journal:  Nat Med       Date:  2021-04-29       Impact factor: 53.440

5.  Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease.

Authors:  Alexandra N Trelle; Valerie A Carr; Edward N Wilson; Michelle S Swarovski; Madison P Hunt; Tyler N Toueg; Tammy T Tran; Divya Channappa; Nicole K Corso; Monica K Thieu; Manasi Jayakumar; Ayesha Nadiadwala; Wanjia Guo; Natalie J Tanner; Jeffrey D Bernstein; Celia P Litovsky; Scott A Guerin; Anna M Khazenzon; Marc B Harrison; Brian K Rutt; Gayle K Deutsch; Frederick T Chin; Guido A Davidzon; Jacob N Hall; Sharon J Sha; Carolyn A Fredericks; Katrin I Andreasson; Geoffrey A Kerchner; Anthony D Wagner; Elizabeth C Mormino
Journal:  Neurology       Date:  2021-01-06       Impact factor: 9.910

6.  Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults.

Authors:  Daniel S Albrecht; Abhay Sagare; Maricarmen Pachicano; Melanie D Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; John C Morris; Tammie Benzinger; Judy Pa
Journal:  Brain Behav Immun       Date:  2021-01-22       Impact factor: 7.217

7.  Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.

Authors:  Daniele Altomare; Camilla Caprioglio; Frédéric Assal; Gilles Allali; Aline Mendes; Federica Ribaldi; Kelly Ceyzeriat; Marta Martins; Szymon Tomczyk; Sara Stampacchia; Alessandra Dodich; Marina Boccardi; Christian Chicherio; Giovanni B Frisoni; Valentina Garibotto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-27       Impact factor: 9.236

Review 8.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

Review 9.  Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  Gérard N Bischof; Alessandra Dodich; Marina Boccardi; Thilo van Eimeren; Cristina Festari; Henryk Barthel; Oskar Hansson; Agneta Nordberg; Rik Ossenkoppele; Osama Sabri; B Frisoni G Giovanni; Valentina Garibotto; Alexander Drzezga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-16       Impact factor: 9.236

10.  Multimodal in vivo and postmortem assessments of tau in Lewy body disorders.

Authors:  David G Coughlin; Jeffrey S Phillips; Emily Roll; Claire Peterson; Rebecca Lobrovich; Katya Rascovsky; Molly Ungrady; David A Wolk; Sandhitsu Das; Daniel Weintraub; Edward B Lee; John Q Trojanowski; Leslie M Shaw; Sanjeev Vaishnavi; Andrew Siderowf; Ilya M Nasrallah; David J Irwin; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2020-08-21       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.